Tho V. Thieu

发表

Copper-Catalyzed Synthesis of 5-Carboxyl-4-perfluoroalkyl Triazoles.

J. Balsells, Robert Panish, Tho V. Thieu, 2021, Organic letters.

Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical Interactions.

Christopher F Stratton, R. DesJarlais, J. Spurlino, 2022, Journal of medicinal chemistry.

Application of cross‐coupling and metalation chemistry of 3(2H)‐pyridazinones to fungicide and herbicide discovery

M. R. Sethuraman, T. Stevenson, Tho V. Thieu, 2005 .

2,7-disubstituted-pyrrolo[2,1-f][1,2,4]triazines: new variant of an old template and application to the discovery of anaplastic lymphoma kinase (ALK) inhibitors with in vivo antitumor activity.

A. Ghose, B. Ruggeri, D. Gingrich, 2011, Journal of medicinal chemistry.

7-fluoroindazoles as potent and selective inhibitors of factor Xa.

Mark R Player, D. Parks, Yu-Kai Lee, 2008, Journal of medicinal chemistry.

Amorphous fluoropolymers from tetrafluoroethylene and bulky vinyl esters or vinyl ethers

B. E. Fischel, A. Feiring, M. Nassirpour, 2002 .

Strategies to mitigate the bioactivation of 2-anilino-7-aryl-pyrrolo[2,1-f][1,2,4]triazines: identification of orally bioavailable, efficacious ALK inhibitors.

K. Wells-Knecht, H. Breslin, B. Dorsey, 2012, Journal of medicinal chemistry.

2,7-Pyrrolo[2,1-f][1,2,4]triazines as JAK2 inhibitors: modification of target structure to minimize reactive metabolite formation.

Jennifer L. Mason, K. L. Milkiewicz, K. Wells-Knecht, 2011, Bioorganic & Medicinal Chemistry Letters.

Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases.

Jennifer L. Mason, P. Dobrzanski, K. L. Milkiewicz, 2012, Bioorganic & medicinal chemistry letters.

Discovery and process synthesis of novel 2,7-pyrrolo[2,1-f][1,2,4]triazines.

A. McLean, H. Breslin, B. Dorsey, 2011, Organic letters.